赵欣,苏鑫,龙德勇,桑才华,何楠,胡荣,杜昕,董建增,马长生

• 1:首都医科大学附属北京安贞医院心内科
• 2:首都医科大学附属北京安贞医院血管外科

摘要(Abstract)：

目的 探讨心房颤动（房颤）合并永久性下腔静脉滤器置入患者经股静脉路径导管消融的可行性与操作策略。方法 纳入首都医科大学附属北京安贞医院自2016年8月至2020年4月接受导管消融的房颤合并永久性下腔静脉滤器置入患者5例。所有患者术前影像学评估滤器和血栓相关情况，术中经股静脉路径行导管消融治疗，术后评估下腔静脉滤器的移位、围术期并发症、术后窦性心律维持情况。结果 5例患者术前影像学评估未发现滤器血栓形成、断裂及移位等情况，均顺利完成导管消融治疗，手术时间为（114.0±21.9）min,X线曝光时间为（8.4±6.5）min，术后未发现滤器明显移位、倾斜。随访19.0(13.5,43.0)个月后，3例患者维持窦性心律，无血栓栓塞、死亡等并发症发生。结论 经充分评估滤器以及优化操作策略后，永久性下腔静脉滤器置入患者经股静脉路径行导管消融安全可行。

关键词(KeyWords)： 心房颤动;永久性下腔静脉滤器;导管消融;血栓栓塞

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目（81600262、81530016）

作者(Author): 赵欣,苏鑫,龙德勇,桑才华,何楠,胡荣,杜昕,董建增,马长生

参考文献(References)：

• [1] Cal kins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation:executive summary[J]. Europace,2018,20(1):157-208.
• [2] Kir chhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fi brillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962.
• [3] Don g JZ, Sang CH, Yu RH, et al. Prospective randomized comparison between a fixed ‘2C3L’ approach vs. stepwise approach for catheter ablation of persistent atrial fi brillation[J].Europace,2015,17(12):1798-1806.
• [4] Bec ker RC. Aspirin and the prevention of venous thromboembolism[J]. N Engl J Med,2012,366(21):2028-2030.
• [5] Bik deli B, Wang Y, Minges KE, et al. Vena caval filter utilization and outcomes in pulmonary embolism:medicare hospitalizations from 1999 to 2010[J]. J Am Coll Cardiol,2016,67(9):1027-1035.
• [6] Dob esh PP. Economic burden of venous thromboembolism in hospitalized patients[J]. Pharmacotherapy,2009,29(8):943-953.
• [7] Kau fman JA. Inferior vena cava filters:current and future concepts[J]. Interv Cardiol Clin,2018,7(1):129-135.
• [8] Was sef A, Lim W, Wu C. Indications, complications and outcomes of inferior vena cava filters:a retrospective study[J]. Thromb Res,2017,153:123-128.
• [9] Duff ett L, Carrier M. Inferior vena cava fi lters[J]. J Thromb Haemost,2017,15(1):3-12.
• [10] Sad ri L, Rogers A, Sharma D, et al. A survey of patients lost to follow-up after inferior vena cava fi lter placement[J]. J Vasc Surg Venous Lymphat Disord,2020,8(3):365-370.
• [11] Mor ris E, Duszak RJ, Sista AK, et al. National trends in inferior vena cava fi lter placement and retrieval procedures in the medicare population over two decades[J]. J Am Coll Radiol,2018,15(8):1080-1086.
• [12] Ha CP, Rectenwald JE. Inferior vena cava filters:current indications, techniques, and recommendations[J]. Surg Clin North Am,2018,98(2):293-319.
• [13]贾中芝，顾建平.下腔静脉滤器图像识别[J].介入放射学杂志，2018,27(2):101-106.
• [14] Pas sman MA. Complications of inferior vena cava fi lters[J]. J Vasc Surg Venous Lymphat Disord,2017,5(1):7.
• [15] Mil ovanovic L, Kennedy SA, Midia M. Procedural a n d indwelling complications with inferior vena cava filters:frequency, etiology, and management[J]. Semin Intervent Radiol,2015,32(1):34-41.
• [16] Sel la DM, Oldenburg WA. Complications of inferior vena cava fi lters[J]. Semin Vasc Surg,2013,26(1):23-28.